Charles Schwab’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
444,456
+19,516
| +5% | +$460K | ﹤0.01% | 1990 |
|
|
2025
Q1 | $10.2M | Sell |
424,940
-5,725
| -1% | -$138K | ﹤0.01% | 1943 |
|
|
2024
Q4 | $18.2M | Buy |
430,665
+68,860
| +19% | +$2.91M | ﹤0.01% | 1749 |
|
|
2024
Q3 | $16M | Buy |
361,805
+10,717
| +3% | +$474K | ﹤0.01% | 1814 |
|
|
2024
Q2 | $12.7M | Buy |
351,088
+12,663
| +4% | +$458K | ﹤0.01% | 1920 |
|
|
2024
Q1 | $14.6M | Buy |
338,425
+60,469
| +22% | +$2.61M | ﹤0.01% | 1790 |
|
|
2023
Q4 | $4.27M | Buy |
277,956
+10,952
| +4% | +$168K | ﹤0.01% | 2376 |
|
|
2023
Q3 | $3.66M | Buy |
267,004
+176,473
| +195% | +$2.42M | ﹤0.01% | 2394 |
|
|
2023
Q2 | $1.45M | Buy |
90,531
+29,112
| +47% | +$467K | ﹤0.01% | 2648 |
|
|
2023
Q1 | $477K | Buy |
61,419
+22,560
| +58% | +$175K | ﹤0.01% | 2965 |
|
|
2022
Q4 | $752K | Buy |
38,859
+969
| +3% | +$18.8K | ﹤0.01% | 2878 |
|
|
2022
Q3 | $808K | Buy |
37,890
+3,199
| +9% | +$68.2K | ﹤0.01% | 2854 |
|
|
2022
Q2 | $473K | Sell |
34,691
-52
| -0.1% | -$709 | ﹤0.01% | 3098 |
|
|
2022
Q1 | $817K | Buy |
34,743
+11,251
| +48% | +$265K | ﹤0.01% | 2930 |
|
|
2021
Q4 | $628K | Buy |
23,492
+6,544
| +39% | +$175K | ﹤0.01% | 3078 |
|
|
2021
Q3 | $295K | Buy |
+16,948
| New | +$295K | ﹤0.01% | 3271 |
|